{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:46:58Z","timestamp":1789015618055,"version":"build-2803163510"},"reference-count":147,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>The COVID-19 pandemic has resulted in significant worldwide morbidity and mortality. In this review, we examine the intricate relationships between COVID-19 and liver diseases. While respiratory manifestations of COVID-19 are well known, its impact and consequences in patients with liver diseases remain an area of ongoing investigation. COVID-19 can induce liver injury through various mechanisms and is associated with higher mortality in individuals with preexisting chronic liver disease. Mortality increases with the severity of chronic liver disease and the level of care required. The outcomes in patients with autoimmune hepatitis remain unclear, whereas liver transplant recipients are more likely to experience symptomatic COVID-19 but have comparable outcomes to the general population. Despite suboptimal immunological response, COVID-19 vaccinations are safe and effective in liver disease, although cases of autoimmune hepatitis-like syndrome have been reported. In conclusion, COVID-19 has significant implications in liver diseases; early recognition and treatments are important for improving patient outcomes.<\/jats:p>","DOI":"10.1055\/a-2157-3318","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T23:10:35Z","timestamp":1692659435000},"page":"351-366","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 and Liver Disease: An Evolving Landscape"],"prefix":"10.1055","volume":"43","author":[{"given":"Kai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Tsai","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljeet","family":"Chahal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"BC Liver Transplant Program, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trana","family":"Hussaini","sequence":"additional","affiliation":[{"name":"BC Liver Transplant Program, Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"BC Liver Transplant Program, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"W J Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2020.05.001","article-title":"AGA Institute Rapid Review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19","volume":"159","author":"S Sultan","year":"2020","journal-title":"Gastroenterology"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"S Richardson","year":"2020","journal-title":"JAMA"},{"issue":"24","key":"ref4","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of COVID-19 in New York City","volume":"382","author":"P Goyal","year":"2020","journal-title":"N Engl J Med"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/hep.31487","article-title":"Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. hospital network","volume":"72","author":"M A Hundt","year":"2020","journal-title":"Hepatology"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical features of patients infected with coronavirus disease 2019 with elevated liver biochemistries: a multicenter, retrospective study","volume":"73","author":"Y Fu","year":"2021","journal-title":"Hepatology"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort","volume":"72","author":"M M Phipps","year":"2020","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"104931","DOI":"10.1016\/j.phrs.2020.104931","article-title":"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study","volume":"158","author":"A Giacomelli","year":"2020","journal-title":"Pharmacol Res"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"10599","DOI":"10.1038\/s41598-021-89513-9","article-title":"Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis","volume":"11","author":"K Bzeizi","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/jmv.26003","article-title":"Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity","volume":"92","author":"J Huang","year":"2020","journal-title":"J Med Virol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13054-020-02995-3","article-title":"The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis","volume":"24","author":"M Aziz","year":"2020","journal-title":"Crit Care"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"V Arroyo","year":"2014","journal-title":"J Hepatol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/joim.13208","article-title":"Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage","volume":"289","author":"M A Wu","year":"2021","journal-title":"J Intern Med"},{"issue":"8432","key":"ref15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(85)91447-3","article-title":"Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury","volume":"1","author":"A Fleck","year":"1985","journal-title":"Lancet"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/antiox9050367","article-title":"N-Acetyl-cysteine regenerates albumin Cys34 by a thiol-disulfide breaking mechanism: an explanation of its extracellular antioxidant activity","volume":"9","author":"A Altomare","year":"2020","journal-title":"Antioxidants"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0040-1721486","article-title":"Albumin supplementation dampens hypercoagulability in COVID-19: a preliminary report","volume":"121","author":"F Violi","year":"2021","journal-title":"Thromb Haemost"},{"issue":"7798","key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"P Zhou","year":"2020","journal-title":"Nature"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Y Wang","year":"2020","journal-title":"J Hepatol"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/liv.14601","article-title":"Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations","volume":"40","author":"A Sonzogni","year":"2020","journal-title":"Liver Int"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000001563","article-title":"Comparison of RNA in situ hybridization and immunohistochemistry techniques for the detection and localization of SARS-CoV-2 in human tissues","volume":"45","author":"L R Massoth","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/liv.14500","article-title":"SARS-CoV-2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID-19","volume":"40","author":"C J Pirola","year":"2020","journal-title":"Liver Int"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"F Qi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.03.931766","article-title":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","author":"X Chai","journal-title":"bioRxiv"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.immunol.25.022106.141706","article-title":"The immunobiology of SARS*","volume":"25","author":"J Chen","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"07","key":"ref26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver functional abnormality","volume":"18","author":"Z Fan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study","volume":"73","author":"D Ji","year":"2020","journal-title":"J Hepatol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.dld.2020.08.004","article-title":"Systemic inflammation as fuel for acute liver injury in COVID-19","volume":"53","author":"M Effenberger","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"M J McConnell","year":"2021","journal-title":"J Hepatol"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jmv.26085","article-title":"Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis","volume":"93","author":"J Zhu","year":"2021","journal-title":"J Med Virol"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"D Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series","volume":"24","author":"A V Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"08","key":"ref33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jclinpath-2020-206623","article-title":"Histopathological features of multiorgan percutaneous tissue core biopsy in patients with COVID-19","volume":"74","author":"X X Wang","year":"2021","journal-title":"J Clin Pathol"},{"issue":"05","key":"ref34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12072-020-10077-3","article-title":"Liver injury in remdesivir-treated COVID-19 patients","volume":"14","author":"R Zampino","year":"2020","journal-title":"Hepatol Int"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/liv.14516","article-title":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19","volume":"40","author":"D Muhovi\u0107","year":"2020","journal-title":"Liver Int"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives","volume":"18","author":"T Marjot","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"J B Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis","volume":"55","author":"L L O'Mahoney","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"07","key":"ref39","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.3390\/ijerph20075281","article-title":"Liver function in patients with long-term coronavirus disease 2019 of up to 20 months: a cross-sectional study","volume":"20","author":"I C de Lima","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3390\/jcm10112507","article-title":"A multidisciplinary approach to evaluate the presence of hepatic and cardiac abnormalities in patients with post-acute COVID-19 syndrome - a pilot study","volume":"10","author":"F Bende","year":"2021","journal-title":"J Clin Med"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"ofac003","DOI":"10.1093\/ofid\/ofac003","article-title":"Metabolic-associated fatty liver disease is highly prevalent in the postacute COVID syndrome","volume":"9","author":"J Milic","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"C Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"T Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Z Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41379-020-00649-x","article-title":"Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data","volume":"33","author":"S M Lagana","year":"2020","journal-title":"Mod Pathol"},{"issue":"7821","key":"ref46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"E J Williamson","year":"2020","journal-title":"Nature"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.cgh.2020.06.011","article-title":"Clinical features and outcomes of coronavirus disease 2019 (COVID-19) patients with chronic hepatitis B virus infection","volume":"18","author":"B Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jmv.26201","article-title":"A case series of COVID-19 patients with chronic hepatitis B virus infection","volume":"92","author":"Y Li","year":"2020","journal-title":"J Med Virol"},{"issue":"22","key":"ref49","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.12998\/wjcc.v8.i22.5831","article-title":"Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?","volume":"8","author":"A Mangia","year":"2020","journal-title":"World J Clin Cases"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV antibody combination and outcomes in outpatients with COVID-19","volume":"385","author":"D M Weinreich","year":"2021","journal-title":"N Engl J Med"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2020-322118","article-title":"Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort","volume":"70","author":"J S Bajaj","year":"2021","journal-title":"Gut"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study","volume":"159","author":"S Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/hep4.1592","article-title":"Clinical features of patients with COVID-19 with nonalcoholic fatty liver disease","volume":"4","author":"R Huang","year":"2020","journal-title":"Hepatol Commun"},{"issue":"05","key":"ref54","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.dsx.2020.06.013","article-title":"Metabolic dysfunction associated fatty liver disease increases risk of severe COVID-19","volume":"14","author":"P Sharma","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17474124.2020.1801417","article-title":"MAFLD in COVID-19 patients: an insidious enemy","volume":"14","author":"P Dongiovanni","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"K Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"e2140568","DOI":"10.1001\/jamanetworkopen.2021.40568","article-title":"Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19","volume":"4","author":"J L Denson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","volume":"74","author":"T Marjot","year":"2021","journal-title":"J Hepatol"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"E Toussirot","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity","volume":"1","author":"G Zandman-Goddard","year":"2002","journal-title":"Autoimmun Rev"},{"key":"ref61","first-page":"472978","article-title":"Human cytomegalovirus and autoimmune disease","author":"A Halenius","year":"2014","journal-title":"BioMed Res Int"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - a systematic review of the literature","volume":"117","author":"L Novelli","year":"2021","journal-title":"J Autoimmun"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study","volume":"56","author":"R Chang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"M K Smatti","year":"2019","journal-title":"Viruses"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"A Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"J Wang","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"15","key":"ref67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"C Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"T Narasaraju","year":"2020","journal-title":"Front Pharmacol"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cells9061383","article-title":"Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19","volume":"9","author":"B Tomar","year":"2020","journal-title":"Cells"},{"issue":"05","key":"ref70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"D Kanduc","year":"2020","journal-title":"Immunol Res"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/imj.15420","article-title":"Autoimmune hepatitis triggered by COVID-19","volume":"51","author":"J Hong","year":"2021","journal-title":"Intern Med J"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jceh.2021.09.007","article-title":"COVID-19 masquerading as autoimmune hepatitis (AIH) flare - the first report","volume":"12","author":"A V Kulkarni","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"ref73","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/liv.15044","article-title":"Autoimmune hepatitis triggered by COVID-19: a report of two cases","volume":"41","author":"G Kaba\u00e7am","year":"2021","journal-title":"Liver Int"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41584-022-00755-x","article-title":"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations","volume":"18","author":"R Grainger","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"07","key":"ref75","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/gutjnl-2021-326784","article-title":"Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic","volume":"71","author":"S Lin","year":"2022","journal-title":"Gut"},{"issue":"11","key":"ref76","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S2468-1253(20)30271-5","article-title":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study","volume":"5","author":"G J Webb","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/ajt.16247","article-title":"SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: a national cohort study","volume":"20","author":"R Ravanan","year":"2020","journal-title":"Am J Transplant"},{"issue":"09","key":"ref78","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus disease 2019 in autoimmune hepatitis: a lesson from immunosuppressed patients","volume":"4","author":"A Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"T Marjot","year":"2021","journal-title":"J Hepatol"},{"issue":"06","key":"ref80","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study","volume":"73","author":"C Efe","year":"2021","journal-title":"Hepatology"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/liv.15121","article-title":"Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis","volume":"42","author":"C Efe","year":"2022","journal-title":"Liver Int"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.31281","article-title":"Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement","volume":"72","author":"O Fix","year":"2020","journal-title":"Hepatology"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.16428","article-title":"Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: a nationwide population-based study","volume":"21","author":"S Trapani","year":"2021","journal-title":"Am J Transplant"},{"issue":"07","key":"ref84","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"M R Pereira","year":"2020","journal-title":"Am J Transplant"},{"issue":"07","key":"ref85","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/ajt.15929","article-title":"COVID-19 in solid organ transplant recipients: a single-center case series from Spain","volume":"20","author":"M Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Am J Transplant"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"J Colmenero","year":"2021","journal-title":"J Hepatol"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1038\/s41598-022-08947-x","article-title":"COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study","volume":"12","author":"M Guarino","year":"2022","journal-title":"Sci Rep"},{"issue":"08","key":"ref88","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/liv.14552","article-title":"Low prevalence and disease severity of COVID-19 in post-liver transplant recipients - a single centre experience","volume":"40","author":"A Verma","year":"2020","journal-title":"Liver Int"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.6002\/ect.2020.0193","article-title":"Coronavirus disease (COVID-19) in kidney and liver transplant patients: a single-center experience","volume":"18","author":"A Akdur","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"12","key":"ref90","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1111\/ajt.16823","article-title":"Liver transplantation from active COVID-19 donors: a lifesaving opportunity worth grasping?","volume":"21","author":"R Romagnoli","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"ref91","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1097\/TXD.0000000000001210","article-title":"Successful liver transplantation in a patient with acute COVID-19 infection and acute liver failure: a case report","volume":"7","author":"K M Kidson","year":"2021","journal-title":"Transplant Direct"},{"issue":"08","key":"ref92","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/ajt.16582","article-title":"Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient","volume":"21","author":"L Yohanathan","year":"2021","journal-title":"Am J Transplant"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"101025","DOI":"10.1016\/j.eclinm.2021.101025","article-title":"Impact of COVID-19 on liver transplant recipients - a systematic review and meta-analysis","volume":"38","author":"A V Kulkarni","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"04","key":"ref95","first-page":"507","article-title":"COVID-19 infection in liver transplant recipients: clinical features and outcomes from a Canadian multicentre cohort","volume":"5","author":"M K Smith","year":"2022","journal-title":"Can Liver J"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"O Abani","year":"2021","journal-title":"Lancet"},{"issue":"08","key":"ref97","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"P Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2020.11.045","article-title":"Protective role of tacrolimus, deleterious role of age and comorbidities in liver Transplant recipients with COVID-19: results from the ELITA\/ELTR multi-center European Study","volume":"160","author":"L S Belli","year":"2021","journal-title":"Gastroenterology"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"756922","DOI":"10.3389\/fmed.2021.756922","article-title":"Immunosuppressants in liver transplant recipients with coronavirus disease 2019: capability or catastrophe?\u2014a systematic review and meta-analysis","volume":"8","author":"D K Yadav","year":"2021","journal-title":"Front Med"},{"issue":"06","key":"ref100","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"A Albillos","year":"2014","journal-title":"J Hepatol"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11894-012-0300-6","article-title":"Immunizations in chronic liver disease: what should be done and what is the evidence","volume":"15","author":"M D Leise","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"issue":"12","key":"ref102","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/v14122778","article-title":"COVID-19 vaccination in patients with chronic liver disease","volume":"14","author":"G Schinas","year":"2022","journal-title":"Viruses"},{"issue":"07","key":"ref103","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cgh.2021.12.022","article-title":"Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): a multicenter study","volume":"20","author":"J Ai","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12072-022-10332-9","article-title":"Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study","volume":"16","author":"J Wang","year":"2022","journal-title":"Hepatol Int"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2021.09.003","article-title":"SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","volume":"20","author":"D F Ruether","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"06","key":"ref106","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2021.08.008","article-title":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","volume":"75","author":"P J Thuluvath","year":"2021","journal-title":"J Hepatol"},{"issue":"08","key":"ref107","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/vaccines10081281","article-title":"Effectiveness of booster dose of anti SARS-CoV-2 BNT162b2 in cirrhosis: longitudinal evaluation of humoral and cellular response","volume":"10","author":"V Giambra","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"02","key":"ref108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/v14020207","article-title":"Antibody responses after SARS-CoV-2 vaccination in patients with liver diseases","volume":"14","author":"A D Bakasis","year":"2022","journal-title":"Viruses"},{"issue":"03","key":"ref109","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/vaccines10030377","article-title":"Patients with liver cirrhosis show high immunogenicity upon COVID-19 vaccination but develop premature deterioration of antibody titers","volume":"10","author":"K Willuweit","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"100697","DOI":"10.1016\/j.jhepr.2023.100697","article-title":"Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease","volume":"5","author":"A L Sim\u00e3o","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"05","key":"ref111","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2022.07.036","article-title":"Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis","volume":"77","author":"B V John","year":"2022","journal-title":"J Hepatol"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jhep.2021.04.026","article-title":"Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study","volume":"75","author":"J Wang","year":"2021","journal-title":"J Hepatol"},{"issue":"06","key":"ref113","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/liv.15173","article-title":"Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection","volume":"42","author":"T He","year":"2022","journal-title":"Liver Int"},{"issue":"12","key":"ref114","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41423-021-00795-5","article-title":"Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection","volume":"18","author":"T Xiang","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"06","key":"ref115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","article-title":"Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome","volume":"76","author":"C Efe","year":"2022","journal-title":"Hepatology"},{"issue":"02","key":"ref116","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"A Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"07","key":"ref117","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cgh.2022.01.012","article-title":"Humoral response to 2-dose BNT162b2 mRNA COVID-19 vaccination in liver transplant recipients","volume":"20","author":"M Guarino","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref118","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jhep.2022.02.015","article-title":"Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients","volume":"77","author":"P Toniutto","year":"2022","journal-title":"J Hepatol"},{"issue":"12","key":"ref119","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/vaccines9121422","article-title":"Humoral immune response following SARS-CoV-2 vaccination in liver transplant recipients","volume":"9","author":"L Timmermann","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"07","key":"ref120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/vaccines9070738","article-title":"Humoral response to SARS-CoV-2 vaccination in liver transplant recipients - a single-center experience","volume":"9","author":"J Rashidi-Alavijeh","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"02","key":"ref121","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"L Rabinowich","year":"2021","journal-title":"J Hepatol"},{"issue":"11","key":"ref122","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses","volume":"326","author":"I Benotmane","year":"2021","journal-title":"JAMA"},{"issue":"07","key":"ref123","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/vaccines9070708","article-title":"Serological response in lung transplant recipients after two doses of SARS-CoV-2 mRNA vaccines","volume":"9","author":"M Narasimhan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(21)01594-4","article-title":"Antibody response after second BNT162b2 dose in allogeneic HSCT recipients","volume":"398","author":"R Redjoul","year":"2021","journal-title":"Lancet"},{"issue":"09","key":"ref125","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"L Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"issue":"10","key":"ref126","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamainternmed.2021.4325","article-title":"Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis","volume":"181","author":"B V John","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"03","key":"ref127","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/hep.32780","article-title":"Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study","volume":"77","author":"J Ge","year":"2023","journal-title":"Hepatology"},{"issue":"05","key":"ref128","doi-asserted-by":"crossref","first-page":"e13705","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients","volume":"23","author":"S Aslam","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"04","key":"ref129","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep4.1853","article-title":"SARS-CoV-2 infections among patients with liver disease and liver transplantation who received COVID-19 vaccination","volume":"6","author":"A M Moon","year":"2022","journal-title":"Hepatol Commun"},{"issue":"04","key":"ref131","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3350\/cmh.2022.0087","article-title":"COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: a meta-analysis","volume":"28","author":"K S Cheung","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"05","key":"ref132","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jhep.2022.06.032","article-title":"Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines","volume":"77","author":"C KH Wong","year":"2022","journal-title":"J Hepatol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"A Vojdani","year":"2020","journal-title":"Clin Immunol"},{"issue":"02","key":"ref134","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5501\/wjv.v12.i2.100","article-title":"Immune-mediated liver injury following COVID-19 vaccination","volume":"12","author":"G Schinas","year":"2023","journal-title":"World J Virol"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1440-1746.2001.02376.x","article-title":"Use of ursodeoxycholic acid in liver diseases","volume":"16","author":"D Kumar","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"ref136","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"12","author":"J S Rudic","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref137","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019","volume":"35","author":"K N Lazaridis","year":"2001","journal-title":"J Hepatol"},{"issue":"01","key":"ref138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(94)00073-C","article-title":"Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children","volume":"66","author":"R Poupon","year":"1995","journal-title":"Pharmacol Ther"},{"issue":"03","key":"ref139","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"G Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"109897","DOI":"10.1016\/j.mehy.2020.109897","article-title":"Ursodeoxycholic acid as a candidate therapeutic to alleviate and\/or prevent COVID-19-associated cytokine storm","volume":"143","author":"S Abdulrab","year":"2020","journal-title":"Med Hypotheses"},{"issue":"02","key":"ref141","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines8020320","article-title":"Merit of an ursodeoxycholic acid clinical trial in COVID-19 patients","volume":"8","author":"S Subramanian","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"572885","DOI":"10.3389\/fchem.2020.572885","article-title":"Hijacking SARS-CoV-2\/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on the receptor binding domain","volume":"8","author":"A Carino","year":"2020","journal-title":"Front Chem"},{"issue":"01","key":"ref143","doi-asserted-by":"crossref","first-page":"22288","DOI":"10.1038\/s41598-021-01705-5","article-title":"Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis","volume":"11","author":"F J Rodal Canales","year":"2021","journal-title":"Sci Rep"},{"issue":"01","key":"ref144","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/acs.jcim.1c01126","article-title":"Discovery of bile acid derivatives as potent ACE2 activators by virtual screening and essential dynamics","volume":"62","author":"B Fiorillo","year":"2022","journal-title":"J Chem Inf Model"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"113021","DOI":"10.1016\/j.biopha.2022.113021","article-title":"Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells","volume":"150","author":"P X Thuy","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"7950","key":"ref146","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"T Brevini","year":"2023","journal-title":"Nature"},{"issue":"05","key":"ref147","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/joim.13630","article-title":"Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis","volume":"293","author":"B V John","year":"2023","journal-title":"J Intern Med"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.21203\/RS.3.RS-2717720\/V1","article-title":"Oral Ursodeoxycholic acid therapy failed to mitigate SARS-CoV-2 omicron variants BA.5.2 infection","author":"D Yu","year":"2023","journal-title":"Research Square"},{"issue":"09","key":"ref152","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.cgh.2022.04.006","article-title":"SARS-CoV-2 vaccine response in patients with autoimmune hepatitis","volume":"20","author":"L Schneider","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2157-3318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:51:09Z","timestamp":1698972669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2157-3318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":147,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,11,1]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2157-3318","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,21]]},"published":{"date-parts":[[2023,8]]}}}